William Blair & Company
VCYT icon

William Blair & Company’s Veracyte VCYT Stock Holding History

William Blair & Company’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.28M Buy
194,887
+3,184
+2% +$118K 0.02% 450
2025
Q4 		$8.07M Buy
191,703
+176,294
+1,144% +$7.11M 0.02% 409
2025
Q3 		$529K Sell
15,409
-550
-3% -$15.8K ﹤0.01% 1096
2025
Q2 		$431K Sell
15,959
-133
-0.8% -$3.85K ﹤0.01% 1135
2025
Q1 		$477K Buy
16,092
+550
+4% +$21K ﹤0.01% 1100
2024
Q4 		$615K Hold
15,542
– – ﹤0.01% 1031
2024
Q3 		$529K Sell
15,542
-162
-1% -$4.56K ﹤0.01% 1099
2024
Q2 		$340K Sell
15,704
-424
-3% -$8.91K ﹤0.01% 1227
2024
Q1 		$357K Sell
16,128
-555
-3% -$13.5K ﹤0.01% 1193
2023
Q4 		$459K Sell
16,683
-23,873
-59% -$576K ﹤0.01% 1093
2023
Q3 		$906K Sell
40,556
-21,776
-35% -$560K ﹤0.01% 872
2023
Q2 		$1.59M Sell
62,332
-1,437
-2% -$34.8K 0.01% 715
2023
Q1 		$1.42M Sell
63,769
-3,241
-5% -$78.3K 0.01% 738
2022
Q4 		$1.59M Sell
67,010
-3,230
-5% -$75.1K 0.01% 698
2022
Q3 		$1.17M Buy
70,240
+27,431
+64% +$617K 0.01% 769
2022
Q2 		$852K Sell
42,809
-13,525
-24% -$273K ﹤0.01% 907
2022
Q1 		$1.55M Sell
56,334
-20,452
-27% -$585K 0.01% 765
2021
Q4 		$3.16M Buy
76,786
+1,229
+2% +$54.3K 0.01% 601
2021
Q3 		$3.51M Buy
75,557
+14,149
+23% +$617K 0.01% 541
2021
Q2 		$2.46M Sell
61,408
-5,535
-8% -$237K 0.01% 648
2021
Q1 		$3.6M Buy
66,943
+26,865
+67% +$1.55M 0.01% 529
2020
Q4 		$1.96M Sell
40,078
-3,985
-9% -$185K 0.01% 657
2020
Q3 		$1.43M Buy
44,063
+8,192
+23% +$260K 0.01% 670
2020
Q2 		$929K Sell
35,871
-2,225
-6% -$55.4K ﹤0.01% 738
2020
Q1 		$926K Sell
38,096
-6,717
-15% -$169K 0.01% 692
2019
Q4 		$1.25M Buy
44,813
+19,863
+80% +$514K 0.01% 721
2019
Q3 		$599K Buy
24,950
+2,500
+11% +$66.5K ﹤0.01% 896
2019
Q2 		$640K Buy
22,450
+7,200
+47% +$180K ﹤0.01% 902
2019
Q1 		$382K Hold
15,250
– – ﹤0.01% 1053
2018
Q4 		$192K Sell
15,250
-1,000
-6% -$11.8K ﹤0.01% 1241
2018
Q3 		$155K Buy
16,250
+1,000
+7% +$11K ﹤0.01% 1326
2018
Q2 		$142K Sell
15,250
-6,600
-30% -$46.4K ﹤0.01% 1307
2018
Q1 		$121K Hold
21,850
– – ﹤0.01% 1252
2017
Q4 		$143K Buy
+21,850
New +$162K ﹤0.01% 1299
2016
Q1 		– Sell
-27,105
Closed -$195K – 1246
2015
Q4 		$195K Sell
27,105
-1,840
-6% -$12.4K ﹤0.01% 1093
2015
Q3 		$135K Hold
28,945
– – ﹤0.01% 1321
2015
Q2 		$322K Buy
+28,945
New +$285K ﹤0.01% 1910

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

William Blair & Company's VCYT Position: Q1 2026 in Review

William Blair & Company increased its Veracyte (VCYT) stake by 1.7% in Q1 2026, buying an estimated $118K and bringing the position to 194,887 shares worth $6.28M. The position accounts for 0.02% of the portfolio, ranked #450.

William Blair & Company first reported a position in VCYT in Q2 2015 and has held it in 37 quarters since. The position peaked at $8.07M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • William Blair & Company held 194,887 shares of Veracyte worth $6.28M as of Q1 2026.
  • William Blair & Company bought 3,184 Veracyte shares in Q1 2026, an estimated $118K.
  • Veracyte made up 0.02% of William Blair & Company's portfolio in Q1 2026, its #450 holding.
  • William Blair & Company first reported a position in Veracyte in Q2 2015 and has held it in 37 quarters since.
  • William Blair & Company's Veracyte position peaked at $8.07M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.